More News

15 Aug 2007 Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
15 Aug 2007 Clinical Phase III Trial Data Demonstrate Valtropin(R)’s Safety and Efficacy
14 Aug 2007 Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Prandin(R)
14 Aug 2007 Oragenics Receives Clinical Hold Letter From FDA
14 Aug 2007 BioMarin partner AnGes MG, Inc. submits BLA to Japanese Ministry of Health
14 Aug 2007 Ophthotech raises $36 million; in-licenses two compounds for macular degeneration
14 Aug 2007 Roche and Actavis agree on product transactions
12 Aug 2007 Novartis withdraws Prexige(R) (lumiracoxib) in Australia in response to
11 Aug 2007 Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin
11 Aug 2007 APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
11 Aug 2007 Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
11 Aug 2007 UK High Court ruled NICE Guidence for Alzheimer's disease discriminatory
11 Aug 2007 Unigene in-licenses potential therapies for inflammation and cardiovascular disease from University of London
11 Aug 2007 Teva Announces Tentative Approval Of Sildenafil Citrate Tablets, 20 Mg
10 Aug 2007 Galapagos announces expanded relationship with AstraZeneca: BioFocus DPI to provide drug discovery services to US-site
10 Aug 2007 Georgetown University and Samaritan sign exclusive licensing agreement for novel treatment of Cushing's syndrome
10 Aug 2007 Johnson & Johnson Statement on Civil Complaint Against The American National Red Cross and Commercial Licensees
10 Aug 2007 ImClone Systems Appoints John H. Johnson Chief Executive Officer
09 Aug 2007 Positive Phase 1b transdermal insulin clincial trial results
09 Aug 2007 DEFLUX(R) significantly reduces urinary tract infections in children with vesicoureteral reflux
09 Aug 2007 Protalix BioTherapeutics signs agreement to license acetylcholinestrase development technology
09 Aug 2007 GeneraMedix Inc. announces FDA approval and launch of three generic injectable products
09 Aug 2007 Biovitrum strengthens its relationship with Wyeth
09 Aug 2007 Aegera Therapeutics Acquires Clinical Stage Oncology Company
09 Aug 2007 Biomira and Merck KGaA sign amended and restated collaboration and supply agreements related to Stimuvax(R)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up